NCT00553150 Everolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Status COMPLETED Phase PHASE1/PHASE2
NCT00551122 Gemcitabine, Paclitaxel, Ifosfamide, and Cisplatin in Treating Patients With Progressive or Relapsed Metastatic Germ Cell Tumors Status UNKNOWN Phase PHASE1/PHASE2
NCT00547131 Temozolomide in Treating Patients With Primary Brain Tumors or Metastatic Brain Tumors Status COMPLETED Phase PHASE1
NCT00544284 Bortezomib and Temozolomide in Treating Patients With Brain Tumors or Other Solid Tumors That Have Not Responded to Treatment Status COMPLETED Phase PHASE1
NCT00541138 Tamoxifen, Carboplatin, and Topotecan in Treating Patients With CNS Metastases or Recurrent Brain or Spinal Cord Tumors Status COMPLETED Phase PHASE2
NCT00521183 Cytochlor, Tetrahydrouridine, and External-Beam Radiation Therapy in Treating Patients With Cancer That Has Spread to the Brain Status COMPLETED Phase PHASE1
NCT00516607 Enzastaurin and Temozolomide in Treating Patients With Primary Gliomas Status UNKNOWN Phase PHASE1
NCT00516282 VNP40101M and Temozolomide in Treating Patients With Progressive or Relapsed Malignant Glioma Status TERMINATED Phase PHASE1
NCT00514397 Temozolomide and Radiation Therapy in Treating Young Patients With Pontine Glioma Status UNKNOWN Phase PHASE2
NCT00513981 High-Dose Methotrexate in Treating Young Patients With Solid Tumors Status COMPLETED Phase PHASE1
NCT00512798 Bortezomib and Temozolomide in Treating Patients With Advanced Refractory Solid Tumors or Melanoma Status TERMINATED Phase PHASE1/PHASE2
NCT00509431 Erlotinib and Sirolimus in Treating Patients With Recurrent Malignant Glioma Status COMPLETED Phase PHASE1
NCT00503724 Enzastaurin in Treating Young Patients With Refractory Primary CNS Tumors Status COMPLETED Phase PHASE1
NCT00499798 Changes in Semen or Sperm Caused by Temozolomide in Patients With Newly Diagnosed, Progressive, or Recurrent Primary Malignant Brain Tumors Status COMPLETED Phase N/A
NCT00498927 Temozolomide in Treating Patients With Recurrent Glioblastoma Multiforme or Other Malignant Glioma Status COMPLETED Phase PHASE2
NCT00492687 Radiation Therapy, Temozolomide, Tamoxifen, and Carboplatin in Treating Patients With Malignant Gliomas Status UNKNOWN Phase PHASE2
NCT00486603 Hydroxychloroquine, Radiation, and Temozolomide Treating Patients With Newly Diagnosed Glioblastoma Multiforme Status COMPLETED Phase PHASE1/PHASE2
NCT00482677 Radiation Therapy With or Without Temozolomide in Treating Older Patients With Newly Diagnosed Glioblastoma Multiforme Status COMPLETED Phase PHASE3
NCT00472017 Vandetanib and Radiation Therapy in Treating Young Patients With Newly Diagnosed Diffuse Brainstem Glioma Status COMPLETED Phase PHASE1
NCT00471653 Pharmacokinetics in Patients With Newly Diagnosed High-Grade Glioma Receiving Temozolomide and Radiation Therapy Status TERMINATED Phase N/A